Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact

About the Cover

December 9, 2013 ;  98 (12)

Cover image

Cover image expansion

Artistic impression of a blood clot: created by somersault18:24. (www.somersault1824.com).

Back to top
PreviousNext

In this issue

Haematologica: 98 (12)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Jump to

  • Editorials and Perspectives
  • Guideline Articles
  • Articles
  • Hematopoiesis & Hematopoietic Stem Cells
  • Myelodysplastic Syndromes
  • Chronic Myeloproliferative Disorders
  • Acute Myeloid Leukemia
  • Acute Leukemia
  • Acute Lymphoblastic Leukemia
  • Non-Hodgkin's Lymphomas
  • Chronic Lymphocytic Leukemia
  • Lymphoproliferative Disorders
  • Stem Cell Transplantation
  • Red Cell Disorders
  • Disorders of Coagulation
  • Obituary
  • Letters to the Editor

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

 
Loading
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online